Long-term follow-up of 114 patients with congenital hyperinsulinism

Clinic of General Pediatrics, University Children's Hospital, Dusseldorf, Germany.

BACKGROUND: The term congenital hyperinsulinism (CHI) comprises a group of different genetic disorders with the common finding of recurrent episodes of hyperinsulinemic hypoglycemia. OBJECTIVE: To evaluate the clinical presentation, diagnostic criteria, treatment and long-term follow-up in a large cohort of CHI patients. PATIENTS: The data from 114 patients from different hospitals were obtained by a detailed questionnaire. Patients presented neonatally (65%), during infancy (28%) or during childhood (7%). RESULTS: In 20 of 74 (27%) patients with neonatal onset birth weight was greatly increased (group with standard deviation scores (SDS) >2.0) with a mean SDS of 3.2. Twenty-nine percent of neonatal-onset vs 69% of infancy/childhood-onset patients responded to diazoxide and diet or to a carbohydrate-enriched diet alone. Therefore, we observed a high rate of pancreatic surgery performed in the neonatal-onset group (70%) compared with the infancy/childhood-onset group (28%). Partial (3%), subtotal (37%) or near total (15%) pancreatectomy was performed. After pancreatic surgery there appeared a high risk of persistent hypoglycemia (40%). Immediately post-surgery or with a latency of several Years insulin-dependent diabetes mellitus was observed in operated patients (27%). General outcome was poor with a high degree of psychomotor or mental retardation (44%) or epilepsy (25%). An unfavorable outcome correlated with infancy-onset manifestation (chi(2)=6.1, P=0.01). CONCLUSIONS: The high degree of developmental delay, in particular in infancy-onset patients emphasizes the need for a change in treatment strategies to improve the unfavorable outcome. Evaluation of treatment alternatives should take the high risk of developing diabetes mellitus into account.

This article has been cited by other articles:

				H. Per, S. Kumandas, A. Coskun, H. Gumus, and D. Oztop Neurologic Sequelae of Neonatal Hypoglycemia in Kayseri, Turkey J Child Neurol, December 1, 2008; 23(12): 1406 - 1412. [Abstract] [PDF]

				W. Barthlen, O. Blankenstein, H. Mau, M. Koch, C. Hohne, W. Mohnike, T. Eberhard, F. Fuechtner, B. Lorenz-Depiereux, and K. Mohnike Evaluation of [18F]Fluoro-L-DOPA Positron Emission Tomography-Computed Tomography for Surgery in Focal Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 869 - 875. [Abstract] [Full Text] [PDF]

				A. A. Palladino, M. J. Bennett, and C. A. Stanley Hyperinsulinism in Infancy and Childhood: When an Insulin Level Is Not Always Enough Clin. Chem., February 1, 2008; 54(2): 256 - 263. [Abstract] [Full Text] [PDF]

				K Mazor-Aronovitch, D Gillis, D Lobel, H J Hirsch, O Pinhas-Hamiel, D Modan-Moses, B Glaser, and H Landau Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism Eur. J. Endocrinol., October 1, 2007; 157(4): 491 - 497. [Abstract] [Full Text] [PDF]

				M. Kim, Z.-X. Yu, B. B. Fredholm, and S. A. Rivkees Susceptibility of the developing brain to acute hypoglycemia involving A1 adenosine receptor activation Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E562 - E569. [Abstract] [Full Text] [PDF]

				M. De Vroede, N.M.A. Bax, K. Brusgaard, M. J. Dunne, and F. Groenendaal Laparoscopic Diagnosis and Cure of Hyperinsulinism in Two Cases of Focal Adenomatous Hyperplasia in Infancy Pediatrics, October 1, 2004; 114(4): e520 - e522. [Abstract] [Full Text] [PDF]

				J. E. McGowan Neonatal Hypoglycemia: Fifty Years Later, The Questions Remain the Same NeoReviews, September 1, 2004; 5(9): e363 - e364. [Full Text] [PDF]